RPRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Repros Therapeutics Inc's quarterly common stock increased from Jun. 2014 ($0.02 Mil) to Sep. 2014 ($0.02 Mil) but then stayed the same from Sep. 2014 ($0.02 Mil) to Dec. 2014 ($0.02 Mil).
Repros Therapeutics Inc's annual common stock increased from Dec. 2012 ($0.02 Mil) to Dec. 2013 ($0.02 Mil) and increased from Dec. 2013 ($0.02 Mil) to Dec. 2014 ($0.02 Mil).
Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.
The par value of common stocks is meaningless. It is usually set at an absurdly low number.
Repros Therapeutics Inc Annual Data
Repros Therapeutics Inc Quarterly Data